Competitive intelligence on
small-molecule drugs and
the 80,000 global patents
covering them

Start your free trial now

No commitment — No credit card required

DrugPatentWatch Ultimate Plan Preview

Details for Generic Name: rizatriptan benzoate

« Back to Dashboard

Summary for Generic Name: rizatriptan benzoate

Tradenames:3
Patents:1
Applicants:13
NDAs:20
Drug Master File Entries: see list21
Suppliers: see list6
Therapeutic Class:Antimigraine Agents

Pharmacology for Ingredient: rizatriptan benzoate

Clinical Trials for: rizatriptan benzoate

Drug Study in Pediatric Subjects With Migraines (MK0462-083 AM1)
Status: Completed Condition: Migraine Disorders

Study of Rizatriptan in the Treatment of Acute Attacks of Post-traumatic Headache in U.S. Military Troops
Status: Recruiting Condition: Chronic Post-traumatic Headache

Rizatriptan 5 mg and 10 mg, Sumatriptan 100 mg, and Placebo Comparison Study (0462-030)
Status: Completed Condition: Migraine Headache

Long-Term Exposure to Rizatriptan 5-mg and 10-mg Oral Tablet (Combined Extension Protocols MK-0462-022, MK-0462-025, MK-0462-029)
Status: Completed Condition: Migraine Disorders

A Study to Evaluate the Efficacy and Tolerability of Rizatriptan for Treatment of Acute Migraine in Children and Adolescents (MK-0462-082 AM7)
Status: Completed Condition: Migraine, Acute

Two Rizatriptan Prescribing Portions for Treatment of Migraine
Status: Completed Condition: Migraine

A Study to Evaluate the Safety and Tolerability of Rizatriptan for Long Term Treatment of Acute Migraine in Children and Adolescents (MK-0462-086 AM3)
Status: Completed Condition: Acute Migraine With or Without Aura in Adolescents

A Study of Rizatriptan for the Treatment of Acute Migraine in Patients on Topiramate for Migraine Prophylaxis
Status: Completed Condition: Migraine

Rizatriptan in Acute Treatment of Migraine in Patients With Unilateral Trigeminal-autonomic Symptoms.
Status: Completed Condition: Migraine

MK0462 5 mg, Sumatriptan 50 mg, and Placebo Comparison Study (0462-029)
Status: Completed Condition: Migraine Headache

Courtesy of ClinicalTrials.org
See more clinical trials for this drug
Glossary
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Invagen Pharms
RIZATRIPTAN BENZOATE
rizatriptan benzoate
TABLET;ORAL204339Jul 1, 2013RXNo<disabled><disabled>
Aurobindo Pharma Ltd
RIZATRIPTAN BENZOATE
rizatriptan benzoate
TABLET;ORAL202490Dec 31, 2012RXNo<disabled><disabled>
Merck
MAXALT-MLT
rizatriptan benzoate
TABLET, ORALLY DISINTEGRATING;ORAL020865Jun 29, 1998RXYes<disabled><disabled>
Cipla Ltd
RIZATRIPTAN BENZOATE
rizatriptan benzoate
TABLET;ORAL077526Mar 26, 2013RXNo<disabled><disabled>
Merck
MAXALT-MLT
rizatriptan benzoate
TABLET, ORALLY DISINTEGRATING;ORAL020865Jun 29, 1998RXNo<disabled><disabled>
This preview shows a limited data set
Subscribe for full access , or try a free trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

DrugPatentWatch Archives

You are viewing the current data set
Select a link below to view the archives:

 2000   2001   2002   2003   2004   2005   2006   2007   2008   2009   2010   2011   2012   2013  

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.

Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Connect with Social Media:

Follow DrugPatentWatch on Twitter Connect with DrugPatentWatch on Linkedin Drug Patents on LinkedIn

Copyright © 2002-2014 thinkBiotech LLC. ISSN: 2162-2639

Other thinkBiotech sites: PatentStatBiotechBlogJournal of Commercial Biotechnology

`abc